Anthera Pharmaceuticals

San Mateo, CA

Nasdaq: ANTH

Anthera Pharmaceuticals is a pharmaceutical development company focused on the advancement of promising clinical products for the treatment of serious inflammatory diseases. Anthera's lead products are inhibitors of secretory phospholipase A2. The lead product is in Phase 3 development for acute coronary syndrome and a second program is in Phase 2b trials to treat patients with lupus.